At The Crossroads, Part 3: As Old Hepatitis C Treatment Fades Out, New Treatments Stoke Hope

In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough medications hitting the market in less than a year.

It’s big news for the estimated twenty thousand Rhode Islanders – and many more throughout New England -  living with chronic hepatitis C. Because some have been waiting decades for a cure.

Next in our series “At The Crossroads: The Rise of Hepatitis C and the Fight to Stop it,” why one man waited so long for treatment.

Listen to the story and read the rest of the story here

Labels: , ,